"Bilim ve İnsan"

During the past decade, Celal Bayar Universitesi Hafsa Sultan Hastanesi conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Celal Bayar Universitesi Hafsa Sultan Hastanesi" #1 sponsor was "Diskapi Teaching and Research Hospital" with 2 trials, followed by "Pfizer" with 2 trials sponsored, "GMG Grand Medical" with 1 trials sponsored, "Immunic AG" with 1 trials sponsored and "Ipsen" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Celal Bayar Universitesi Hafsa Sultan Hastanesi" #1 collaborator was "Gama CRO Tıbbi İlaç Araştırma Org.Tic.Ltd.Şti" with 1 trials as a collaborator, "PRA Health Sciences" with 1 trials as a collaborator and "Turkish Society of Anesthesiology and Reanimation" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Celal Bayar Universitesi Hafsa Sultan Hastanesi" are "Blood Transfusion" (2 trials), "Anemia" (1 trials), "Blood Loss Anemia" (1 trials), "Blood Loss, Surgical" (1 trials) and "Chronic Kidney Disease" (1 trials). Many other conditions were trialed in "Celal Bayar Universitesi Hafsa Sultan Hastanesi" in a lesser frequency.

Most popular intervention types in "Celal Bayar Universitesi Hafsa Sultan Hastanesi" are "Drug" (5 trials), "Other" (2 trials), "Biological" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Blood transfusion" (2 trials), "Ceftazidime -avibactam" (2 trials), "Botulinum toxin type A" (1 trials), "Calcium Carbonate" (1 trials) and "Cefepime" (1 trials). Other intervention names were less common.

The vast majority of trials in "Celal Bayar Universitesi Hafsa Sultan Hastanesi" are 7 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Celal Bayar Universitesi Hafsa Sultan Hastanesi". 1 are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Celal Bayar Universitesi Hafsa Sultan Hastanesi, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Celal Bayar Universitesi Hafsa Sultan Hastanesi, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".